{"id":"https://openalex.org/W4387826331","doi":"https://doi.org/10.1016/j.annonc.2023.09.702","title":"838P Matching-adjusted indirect comparison (MAIC) of axicabtagene ciloleucel (axi-cel) and epcoritamab (epcor) in relapsed/refractory (R/R) large B cell lymphoma (LBCL) after at least two prior systemic therapies (3L+)","display_name":"838P Matching-adjusted indirect comparison (MAIC) of axicabtagene ciloleucel (axi-cel) and epcoritamab (epcor) in relapsed/refractory (R/R) large B cell lymphoma (LBCL) after at least two prior systemic therapies (3L+)","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387826331","doi":"https://doi.org/10.1016/j.annonc.2023.09.702"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2023.09.702","doi":"https://doi.org/10.1016/j.annonc.2023.09.702","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.702","pdf_url":"http://www.annalsofoncology.org/article/S0923753423015387/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753423015387/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040504519","display_name":"Olalekan O. Oluwole","orcid":"https://orcid.org/0000-0001-8525-9641","observed_orcids":["https://orcid.org/0000-0001-8525-9641"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O.O. Oluwole","raw_affiliation_strings":["Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M.D. Ray","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.D. Ray","raw_affiliation_strings":["Health Economics&Outcomes Research, Kite, a Gilead Company, Santa Monica, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics&Outcomes Research, Kite, a Gilead Company, Santa Monica, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043705242","display_name":"J.M. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.M. Chen","raw_affiliation_strings":["Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022764809","display_name":"Keith W Chan","orcid":"https://orcid.org/0000-0003-3262-3563","observed_orcids":["https://orcid.org/0000-0003-3262-3563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Chan","raw_affiliation_strings":["Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"I. Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Zhang","raw_affiliation_strings":["Evidence Synthesis, PRECISIONheor, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Synthesis, PRECISIONheor, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031295196","display_name":"Sam Keeping","orcid":"https://orcid.org/0000-0002-4281-1536","observed_orcids":["https://orcid.org/0000-0002-4281-1536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Keeping","raw_affiliation_strings":["Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidence Synthesis, PRECISIONheor, Vancouver, BC, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Smith","raw_affiliation_strings":["Global Medical Affairs, Kite, a Gilead Company, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Kite, a Gilead Company, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022878340","display_name":"Clare Spooner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.L. Bellasis Spooner","raw_affiliation_strings":["Global Medical Affairs, Kite, a Gilead Company, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Kite, a Gilead Company, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101611102","display_name":"Anik R. Patel","orcid":"https://orcid.org/0000-0001-9091-8904","observed_orcids":["https://orcid.org/0000-0001-9091-8904"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.R. Patel","raw_affiliation_strings":["Health Economics&Outcomes Research, Kite, a Gilead Company, Santa Monica, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics&Outcomes Research, Kite, a Gilead Company, Santa Monica, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021394406","display_name":"Frederick Lundry Locke","orcid":"https://orcid.org/0000-0001-9063-6691","observed_orcids":["https://orcid.org/0000-0001-9063-6691"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F.L. Locke","raw_affiliation_strings":["Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center University of South Florida, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center University of South Florida, Tampa, FL, USA","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4060,"currency":"USD","value_usd":4060},"apc_paid":null,"fwci":0.6277,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.68354243,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"34","issue":null,"first_page":"S548","last_page":"S548"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.07270000129938126,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9909999966621399},{"id":"https://openalex.org/keywords/epcoritamab","display_name":"epcoritamab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/relapsed-refractory-large-b-cell-lymphoma","display_name":"relapsed/refractory large B-cell lymphoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/matching-adjusted-indirect-comparison","display_name":"matching-adjusted indirect comparison","score":0.8899999856948853},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9879999756813049},{"id":"https://openalex.org/keywords/head-to-head-comparison","display_name":"head-to-head comparison","score":0.6389999985694885},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8690705299377441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.597602367401123},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5218528509140015},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5191737413406372},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4515978693962097},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3308912515640259},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3235090970993042},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.13749852776527405}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2023.09.702","doi":"https://doi.org/10.1016/j.annonc.2023.09.702","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.702","pdf_url":"http://www.annalsofoncology.org/article/S0923753423015387/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2023.09.702","doi":"https://doi.org/10.1016/j.annonc.2023.09.702","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.09.702","pdf_url":"http://www.annalsofoncology.org/article/S0923753423015387/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7099999785423279,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387826331.pdf","grobid_xml":"https://content.openalex.org/works/W4387826331.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W4387826331"],"related_works":["https://openalex.org/W2793335702","https://openalex.org/W4210646467","https://openalex.org/W2154948599","https://openalex.org/W2792027122","https://openalex.org/W4254083861","https://openalex.org/W2913113213","https://openalex.org/W2090763189","https://openalex.org/W2792916732","https://openalex.org/W2921331952","https://openalex.org/W2914671834"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}